Overview
William Finn is a Hematologist practicing medicine in Ypsilanti, Michigan.
Dr. Finn is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, GTP Cyclohydrolase 1 Deficiency, and Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency.
He is actively involved in clinical research, co-authoring 6 peer reviewed articles.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
5301 McAuley Dr, Ypsilanti, MI 48197
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
C. S. Mott Children's Hospital
Dr. Dale Bixby has been practicing hematology at the University of Michigan since 2009. He obtained his PhD in Medicinal Chemistry and Pharmaceutics at the University of Kentucky in 1999, before beginning his medical training at the University of Michigan in Ann Arbor, MI. He was a resident in the Department of Internal Medicine and then completed fellowship training in hematology and medical oncology at the University of Michigan. Dr. Bixby is currently a clinical professor and specializes in the areas of myeloid and lymphoid leukemias, myelodysplastic syndrome and bone marrow failure disorders. Dr. Bixby currently serves as the section chief of the acute leukemia program. He is also a clinical investigator in hematological malignancies. Dr. Bixby is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Chronic Myelogenous Leukemia (CML), and Bone Marrow Aspiration. Dr. Bixby is board certified in Hematology. Dr. Bixby is currently accepting new patients.
Rogel Cancer Center
Erica Campagnaro is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Campagnaro is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Campagnaro is board certified in Hematology and Internal Medicine. Dr. Campagnaro is currently accepting new patients.
University Of Michigan Medical Center
Rajen Mody is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Mody is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Gliomatosis Cerebri, Neuroepithelioma, and Bone Marrow Aspiration. Dr. Mody is currently accepting new patients.
Frequently Asked Questions about Dr. William G. Finn
How do I make an appointment with Dr. William G. Finn?
You can book an appointment with Dr. William G. Finn by calling their office at 734-712-3161. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. William G. Finn a top-rated expert for Monoclonal Gammopathy of Undetermined Significance (MGUS)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. William G. Finn is classified as an Advanced expert for Monoclonal Gammopathy of Undetermined Significance (MGUS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. William G. Finn specialize in?
While Dr. William G. Finn is a Hematology, they have specific expertise in Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, and GTP Cyclohydrolase 1 Deficiency. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. William G. Finn participate in research or clinical trials?
Yes. Dr. William G. Finn has published 6 articles and abstracts on conditions like Monoclonal Gammopathy of Undetermined Significance (MGUS). You can view a list of Dr. William G. Finn's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency
- GTP Cyclohydrolase 1 Deficiency
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Pseudocholinesterase Deficiency
- Schnitzler SyndromeDr. Finn isAdvanced. Learn about Schnitzler Syndrome.
- Experienced
- AgranulocytosisDr. Finn isExperienced. Learn about Agranulocytosis.
- AnemiaDr. Finn isExperienced. Learn about Anemia.
- Congenital Hemolytic AnemiaDr. Finn isExperienced. Learn about Congenital Hemolytic Anemia.
- Cyclic NeutropeniaDr. Finn isExperienced. Learn about Cyclic Neutropenia.
- Hemolytic AnemiaDr. Finn isExperienced. Learn about Hemolytic Anemia.
- Hemolytic CrisisDr. Finn isExperienced. Learn about Hemolytic Crisis.
- Multiple MyelomaDr. Finn isExperienced. Learn about Multiple Myeloma.
- Sickle Cell DiseaseDr. Finn isExperienced. Learn about Sickle Cell Disease.
- Smoldering Multiple MyelomaDr. Finn isExperienced. Learn about Smoldering Multiple Myeloma.
- ThalassemiaDr. Finn isExperienced. Learn about Thalassemia.
- ThrombocytopeniaDr. Finn isExperienced. Learn about Thrombocytopenia.

